Form D · Pharmaceuticals

Seldar Pharma, Inc.

Bridgewater, NJ · CIK 0001552224

Offering snapshot reported Dec 11, 2013 · SEC filing

Reported sold
$13M
Offering amount: $13M
Investors reported
22
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 31, 2012
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$6.5M$13MJun 14, 2012: $5,199,470.00Jun 14, 2012Dec 11, 2013: $12,999,000.00Dec 11, 2013

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$5,199,470 → $12,999,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 11, 2013Amendment$12,999,000$7,799,530vs Jun 14, 201222SEC filing
Jun 14, 2012Initial$5,199,470No comparison22SEC filing

Offering details

Securities
Equity, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-179783

Source: Form D, filed Dec 11, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jeffrey Bird Director
Christopher Del Mastro Executive
Robert Desjardins Director, Executive, Promoter
Arnold Oronsky Director
Donna L. Tempel Director, Executive, Promoter

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
520 Us Highway 22 Suite 201
Bridgewater, NJ, 08807